511 results on '"Fröhling S"'
Search Results
2. Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
3. Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial
4. The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
5. Mechanismen der Kardiotoxizität onkologischer Therapien
6. Mechanismen der Kardiotoxizität onkologischer Therapien
7. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial
8. Optimizing panel-based tumor mutational burden (TMB) measurement
9. Von der Paneldiagnostik zu umfassenden genomischen Analysen: Informationsüberfluss oder Zugewinn?
10. RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
11. The German Network for Personalized Medicine to enhance patient care and translational research
12. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma
13. Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution
14. 8P Targeting antiapoptotic Bcl-2 proteins with highly specific BH3 mimetics in solid tumors
15. 99P Fibroblast activation protein alpha (FAP) as theranostic target in solitary fibrous tumor
16. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
17. Targeted therapies in the treatment of ovarian granulosa cell tumours – a monocentric case series
18. Personalisierte Onkologie
19. JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia
20. Dissection of CD20 regulation in lymphoma using RNAi
21. Application of precision medicine in clinical routine in haematology - challenges and opportunities
22. Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours
23. 668P Comprehensive analysis of the tumor immune microenvironment (TIM) in advanced adenoid cystic (ACC) and non-adenoid cystic salivary gland cancers (SGC)
24. 1490MO CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)
25. 487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies
26. Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling
27. Identification of Partial Tandem Duplications of the MLL Gene in Acute Myeloid Leukemia: Prospective Analysis within the Multicenter Treatment Trial AML HD98-A
28. Chemotherapy and All-Trans Retinoic Acid in Patients >60 Years with Acute Myeloid Leukemia: First Results of the Multicenter Treatment Trial AML HD98-B
29. Stratification of Postremission Therapy in Patients with Acute Myeloid Leukemia < 60 Years According to the Karyotype: Results of the German Multicenter Treatment Trials AML HD93 and AML HD98-A
30. Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders
31. Anti‐programmed cell death‐1 therapy in nonmelanoma skin cancer
32. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia
33. Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
34. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway
35. 1533P Gene expression-based prediction of pazopanib benefit in sarcomas
36. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*
37. 2318P Value of broad molecular profiling for cancer diagnosis
38. 2320P Detection of gene fusion-induced neoepitopes in dedifferentiated liposarcoma
39. 1940P Deep molecular profiling of advanced synovial sarcoma as a basis for interventional clinical trials
40. 1936P Targeted therapy of desmoplastic small round cell tumor guided by multilayered molecular profiling
41. 187P Ipatasertib and atezolizumab in cancers with increased PI3K-AKT pathway activity: First results from the CRAFT trial
42. 131O A composite biomarker for evaluation of homologous recombination repair deficiency in a pan-cancer cohort
43. Gene expression-based prediction of pazopanib benefit in sarcomas
44. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance
45. EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe
46. Molecular characterization of metastatic eccrine porocarcinoma
47. Supplement to: Chromosomal abnormalities in cancer.
48. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
49. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
50. hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.